August 6, 2026 FDA approves Replimune melanoma drug previously rejected twice Portfolio Company News Read more
July 29, 2026 Less than year after launch, Caldera lines up $278M financing and Nasdaq debut Portfolio Company News Read more
July 28, 2026 Evolving Drug Discovery: AI, Infrastructure, and the Speed of Learning From the Trenches Read more
July 17, 2026 The Plus-1 in “The Room Where It Happens”: A Survival Guide for Board Observers From the Trenches Read more